T1	Participants 509 573	women with equivocal (ASCUS) or mildly abnormal (LSIL) Pap tests
T2	Participants 619 697	608 women had a histopathologic diagnosis of CIN3 and PCR-based HPV genotyping
T3	Participants 892 921	608 women diagnosed with CIN3
